Skip to main content
. Author manuscript; available in PMC: 2011 Nov 14.
Published in final edited form as: Oral Oncol. 2008 Mar 7;44(10):915–919. doi: 10.1016/j.oraloncology.2008.01.001

Table 1.

Demographic and Risk Factors By HPV-16 Status

Variables HPV-16negative HPV-16positive p-value
Gender
Male 30 (76.9) 18 (90.0) 0.222
Female 9 (23.1) 2 (10.0)
Age
<50yr 10 (25.6) 7 (35.0) 0.621
50–64yr 22 (56.4) 11 (55.0)
≥65yr 7 (18.0) 2 (10.0)
Race
Caucasian 27 (69.2) 20 (100.0) 0.021
African American 10 (25.7) 0 (0.0)
Other 2 (5.1) 0 (0.0)
Smoking status
Never 12 (30.8) 7 (35.0) 0.257
Former 6 (15.4) 7 (35.0)
Current 17 (43.6) 5 (25.0)
Unknown 4 (10.2) 1 (5.0)
Drinking status
Never 8 (20.5) 2 (10.0) 0.585
Former 4 (10.3) 1 (5.0)
Current 19 (48.7) 13 (65.0)
Unknown 8 (20.5) 4 (20.0)
Stage
Early (I–II) 17 (44.7) 1 (5.26) 0.003
Advanced (III–IV) 21 (55.3) 18 (94.74)
TNM
Tumor
1 16 (42.1) 7 (36.84) 0.574
2 11 (28.9) 7 (36.84)
3 8 (21.1) 5 (26.32)
4 3 (7.9) 0 (0.0)
Lymph Node
N− 22 (56.4) 2 (10.0) 0.001
N+ 17 (43.6) 18 (90.0)
Tumor Site
Oropharynx 4 (10.2) 19 (95.0) <0.001
Oral cavity 23 (59.0) 0
Larynx 9 (23.1) 0
Hypopharynx 2 (5.1) 0
Unknown primary 1 (2.6) 1 (5.0)